BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36329776)

  • 21. Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research.
    Sarro L; Nanetti L; Castaldo A; Mariotti C
    Expert Rev Neurother; 2017 Sep; 17(9):919-931. PubMed ID: 28805093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the Scale for Assessment and Rating of Ataxia (SARA).
    Yabe I; Matsushima M; Soma H; Basri R; Sasaki H
    J Neurol Sci; 2008 Mar; 266(1-2):164-6. PubMed ID: 17950753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinocerebellar ataxia.
    Klockgether T; Mariotti C; Paulson HL
    Nat Rev Dis Primers; 2019 Apr; 5(1):24. PubMed ID: 30975995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits.
    Velázquez-Pérez L; Rodriguez-Labrada R; González-Garcés Y; Arrufat-Pie E; Torres-Vega R; Medrano-Montero J; Ramirez-Bautista B; Vazquez-Mojena Y; Auburger G; Horak F; Ziemann U; Gomez CM
    Mov Disord; 2021 Feb; 36(2):471-480. PubMed ID: 33107647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.
    Agnese S; Chiara C; Radouil T; Iveta C; Francesco P; Gianmarco B; Marco S; Theresa Z; Giovanni R; Silvia R
    Cerebellum; 2024 Jul; ():. PubMed ID: 38976217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized exergame training improves postural control in advanced degenerative spinocerebellar ataxia: A rater-blinded, intra-individually controlled trial.
    Schatton C; Synofzik M; Fleszar Z; Giese MA; Schöls L; Ilg W
    Parkinsonism Relat Disord; 2017 Jun; 39():80-84. PubMed ID: 28365204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speech in spinocerebellar ataxia.
    Schalling E; Hartelius L
    Brain Lang; 2013 Dec; 127(3):317-22. PubMed ID: 24182841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies.
    Coutelier M; Coarelli G; Monin ML; Konop J; Davoine CS; Tesson C; Valter R; Anheim M; Behin A; Castelnovo G; Charles P; David A; Ewenczyk C; Fradin M; Goizet C; Hannequin D; Labauge P; Riant F; Sarda P; Sznajer Y; Tison F; Ullmann U; Van Maldergem L; Mochel F; Brice A; Stevanin G; Durr A;
    Brain; 2017 Jun; 140(6):1579-1594. PubMed ID: 28444220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cerebellar ataxias: A three-year prospective longitudinal assessment.
    Lee YC; Liao YC; Wang PS; Lee IH; Lin KP; Soong BW
    Mov Disord; 2011 Sep; 26(11):2081-7. PubMed ID: 21626567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.
    Oz G; Iltis I; Hutter D; Thomas W; Bushara KO; Gomez CM
    Cerebellum; 2011 Jun; 10(2):208-17. PubMed ID: 20838948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3.
    Wang RY; Huang FY; Soong BW; Huang SF; Yang YR
    Sci Rep; 2018 May; 8(1):7816. PubMed ID: 29777115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spinocerebellar ataxia type 8 in Russian patients].
    Nuzhnyi EP; Abramycheva NY; Chkhartishvili IA; Protopopova AO; Fedotova EY; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):106-111. PubMed ID: 36036411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
    Tanguy Melac A; Mariotti C; Filipovic Pierucci A; Giunti P; Arpa J; Boesch S; Klopstock T; Müller Vom Hagen J; Klockgether T; Bürk K; Schulz JB; Reetz K; Pandolfo M; Durr A; Tezenas du Montcel S;
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):559-565. PubMed ID: 29279305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.
    Koutsis G; Kladi A; Karadima G; Houlden H; Wood NW; Christodoulou K; Panas M
    J Neurol Sci; 2014 Jan; 336(1-2):87-92. PubMed ID: 24209901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study.
    Fonteyn EM; Schmitz-Hübsch T; Verstappen CC; Baliko L; Bloem BR; Boesch S; Bunn L; Charles P; Dürr A; Filla A; Giunti P; Globas C; Klockgether T; Melegh B; Pandolfo M; De Rosa A; Schöls L; Timmann D; Munneke M; Kremer BP; van de Warrenburg BP
    Cerebellum; 2010 Jun; 9(2):232-9. PubMed ID: 20157791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
    Aguiar P; Pardo J; Arias M; Quintáns B; Fernández-Prieto M; Martínez-Regueiro R; Pumar JM; Silva-Rodríguez J; Ruibal Á; Sobrido MJ; Cortés J
    Mov Disord; 2017 Feb; 32(2):264-273. PubMed ID: 27862279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays.
    Scott SSO; Pedroso JL; Barsottini OGP; França-Junior MC; Braga-Neto P
    J Neurol Sci; 2020 Oct; 417():117082. PubMed ID: 32791425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower urinary tract and bowel dysfunction in spinocerebellar ataxias.
    Afonso Ribeiro J; Simeoni S; De Min L; Uchiyama T; Tung Lo Y; Solanky N; Garcia-Moreno H; Giunti P; Panicker JN
    Ann Clin Transl Neurol; 2021 Feb; 8(2):321-331. PubMed ID: 33338328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.